Doxorubicin

epidermal growth factor receptor ; Homo sapiens







107 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 34893239 Carboxylated chitosan-mediated improved efficacy of mesoporous silica nanoparticle-based targeted drug delivery system for breast cancer therapy. 2022 Feb 1 1
2 34985285 Asparaginyl Endopeptidase-Mediated Protein C-Terminal Hydrazinolysis for the Synthesis of Bioconjugates. 2022 Jan 19 1
3 34998092 Targeting immunoliposomes to EGFR-positive glioblastoma. 2022 Feb 8
4 35167278 EGFR Ligand Clustering on E2 Bionanoparticles for Targeted Delivery of Chemotherapeutics to Breast Cancer Cells. 2022 Mar 16 1
5 35214137 Photosensitive EGFR-Targeted Nanocarriers for Combined Photodynamic and Local Chemotherapy. 2022 Feb 13 3
6 33111200 Transcriptome analysis of the circadian clock gene BMAL1 deletion with opposite carcinogenic effects. 2021 Jan 1
7 33115283 Combination treatment strategies with a focus on rosiglitazone and adriamycin for insulin resistant liver cancer. 2021 Mar 1
8 33509300 Epigenetic immunomodulatory effect of eugenol and astaxanthin on doxorubicin cytotoxicity in hormonal positive breast Cancer cells. 2021 Jan 28 3
9 33691834 Preparation of Epidermal Growth Factor-Modified Targeted Doxorubicin Nanoliposomes and Therapy of Liver Cancer. 2021 Sep 1 3
10 33814909 EGFR Targeted Cetuximab-Valine-Citrulline (vc)-Doxorubicin Immunoconjugates- Loaded Bovine Serum Albumin (BSA) Nanoparticles for Colorectal Tumor Therapy. 2021 7
11 34023418 GABRP sustains the stemness of triple-negative breast cancer cells through EGFR signaling. 2021 Aug 28 1
12 34096285 pH-Controlled Protein Orthogonal Ligation Using Asparaginyl Peptide Ligases. 2021 Jun 16 1
13 34119884 Urinary exosomes-based Engineered Nanovectors for Homologously Targeted Chemo-Chemodynamic Prostate Cancer Therapy via abrogating EGFR/AKT/NF-kB/IkB signaling. 2021 Aug 3
14 34298600 Ultrasound-Mediated Cavitation Enhances EGFR-Targeting PLGA-PEG Nano-Micelle Delivery for Triple-Negative Breast Cancer Treatment. 2021 Jul 6 3
15 34600360 Capsule-like molecular imprinted polymer nanoparticles for targeted and chemophotothermal synergistic cancer therapy. 2021 Dec 2
16 34830320 Doxorubicin-Resistant TNBC Cells Exhibit Rapid Growth with Cancer Stem Cell-like Properties and EMT Phenotype, Which Can Be Transferred to Parental Cells through Autocrine Signaling. 2021 Nov 18 1
17 31883395 Modeling Neoadjuvant chemotherapy resistance in vitro increased NRP-1 and HER2 expression and converted MCF7 breast cancer subtype. 2020 May 1
18 32866592 Epidermal growth factor (EGF)-based activatable probe for predicting therapeutic outcome of an EGF-based doxorubicin prodrug. 2020 Dec 10 2
19 33022466 Therapeutic resistance in breast cancer cells can result from deregulated EGFR signaling. 2020 Dec 1
20 30589193 Selective Delivery of Doxorubicin to EGFR+ Cancer Cells by Cetuximab-DNA Conjugates. 2019 Apr 15 4
21 30677497 Sortagged anti-EGFR immunoliposomes exhibit increased cytotoxicity on target cells. 2019 Mar 1
22 31188543 LncRNA LOXL1-AS1/miR-let-7a-5p/EGFR-related pathway regulates the doxorubicin resistance of prostate cancer DU-145 cells. 2019 Oct 1
23 31298380 Effect of miR-7 on resistance of breast cancer cells to adriamycin via regulating EGFR/PI3K signaling pathway. 2019 Jun 2
24 31299626 Time-staggered delivery of erlotinib and doxorubicin by gold nanocages with two smart polymers for reprogrammable release and synergistic with photothermal therapy. 2019 Oct 6
25 31356633 Effective treatment of cancer metastasis using a dual-ligand nanoparticle. 2019 1
26 31534505 Ultrasound-mediated cavitation enhances the delivery of an EGFR-targeting liposomal formulation designed for chemo-radionuclide therapy. 2019 2
27 31545462 Lung carcinoma therapy using epidermal growth factor receptor‑targeted lipid polymeric nanoparticles co‑loaded with cisplatin and doxorubicin. 2019 Nov 5
28 31704984 Cell proliferation and invasion are regulated differently by EGFR and MRP1 in T-DM1-resistant breast cancer cells. 2019 Nov 8 1
29 29570299 GE11-Directed Functional Polymersomal Doxorubicin as an Advanced Alternative to Clinical Liposomal Formulation for Ovarian Cancer Treatment. 2018 Sep 4 2
30 29855103 Black Phosphorus Quantum Dots Gated, Carbon-Coated Fe3 O4 Nanocapsules (BPQDs@ss-Fe3 O4 @C) with Low Premature Release Could Enable Imaging-Guided Cancer Combination Therapy. 2018 Sep 3 7
31 29969563 Specific Drug Delivery to Cancer Cells with Double-Imprinted Nanoparticles against Epidermal Growth Factor Receptor. 2018 Aug 8 2
32 30240496 Design of a Multicompartment Hydrogel that Facilitates Time-Resolved Delivery of Combination Therapy and Synergized Killing of Glioblastoma. 2018 Nov 12 1
33 27902463 Novel multi-targeted ErbB family inhibitor afatinib blocks EGF-induced signaling and induces apoptosis in neuroblastoma. 2017 Jan 3 1
34 28229963 Constitutively activated ERK sensitizes cancer cells to doxorubicin: Involvement of p53-EGFR-ERK pathway. 2017 Mar 1
35 28435266 EGFR-targeted delivery of DOX-loaded Fe3O4@ polydopamine multifunctional nanocomposites for MRI and antitumor chemo-photothermal therapy. 2017 8
36 28482611 Cetuximab conjugated and doxorubicin loaded silica nanoparticles for tumor-targeting and tumor microenvironment responsive binary drug delivery of liver cancer therapy. 2017 Jul 1 1
37 28593948 Conditional internalization of PEGylated nanomedicines by PEG engagers for triple negative breast cancer therapy. 2017 Jun 8 2
38 28688985 Mussel-inspired PLGA/polydopamine core-shell nanoparticle for light induced cancer thermochemotherapy. 2017 Sep 1 1
39 28776259 Increased EGFR expression induced by a novel oncogene, CUG2, confers resistance to doxorubicin through Stat1-HDAC4 signaling. 2017 Dec 5
40 29030307 EGFR-targeted multifunctional polymersomal doxorubicin induces selective and potent suppression of orthotopic human liver cancer in vivo. 2017 Dec 4
41 29077410 Delayed Sequential Co-Delivery of Gefitinib and Doxorubicin for Targeted Combination Chemotherapy. 2017 Dec 4 4
42 26176268 Epidermal growth factor receptor-targeted peptide conjugated phospholipid micelles for doxorubicin delivery. 2016 1
43 26505786 Combinatorial Effects of Curcumin with an Anti-Neoplastic Agent on Head and Neck Squamous Cell Carcinoma Through the Regulation of EGFR-ERK1/2 and Apoptotic Signaling Pathways. 2016 Jan 11 1
44 26945977 Co-delivery of erlotinib and doxorubicin by pH-sensitive charge conversion nanocarrier for synergistic therapy. 2016 May 10 5
45 27050167 Targeted Doxorubicin Delivery to Brain Tumors via Minicells: Proof of Principle Using Dogs with Spontaneously Occurring Tumors as a Model. 2016 1
46 27191929 Sendai viroplexes for epidermal growth factor receptor-directed delivery of interleukin-12 and salmosin genes to cancer cells. 2016 Jul 1
47 27420618 [Implication of integrin alpha5beta1 signal pathways in proliferation and apoptosis of MCF-7/Dox human breast carcinoma cells]. 2016 Mar 2
48 24798787 Enhancement of tumor uptake and therapeutic efficacy of EGFR-targeted antibody cetuximab and antibody-drug conjugates by cholesterol sequestration. 2015 Jan 1 1
49 25553823 Tumor-penetrating peptide fused EGFR single-domain antibody enhances cancer drug penetration into 3D multicellular spheroids and facilitates effective gastric cancer therapy. 2015 Feb 28 2
50 25662498 Target-specific near-IR induced drug release and photothermal therapy with accumulated Au/Ag hollow nanoshells on pulmonary cancer cell membranes. 2015 Mar 14